https://frankvanleth.com https://frankvanleth.com/publications https://frankvanleth.com/projects https://frankvanleth.com/people https://frankvanleth.com/courses https://frankvanleth.com/posts https://frankvanleth.com/pages https://frankvanleth.com/cv https://frankvanleth.com/contact_form https://frankvanleth.com/publications/52244-untitled https://frankvanleth.com/publications/50898-diagnostic-accuracy-and-predictive-value-of-the-quantiferon-tb-gold-plus-assay-for-tuberculosis-in-immunocompromised-individuals-a-prospective-tbnet-study https://frankvanleth.com/publications/50899-syndemic-processes-between-non-communicable-diseases-and-hiv-within-the-kingdom-of-eswatini https://frankvanleth.com/publications/50901-statistical-methods-to-adjust-for-treatment-switching-in-real-world-clinical-studies-a-scoping-review-and-descriptive-comparison https://frankvanleth.com/publications/50900-assessing-the-quality-of-amoxicillin-in-the-private-market-in-indonesia-a-cross-sectional-survey-exploring-product-variety-market-volume-and-price-factors https://frankvanleth.com/publications/47380-the-opportunities-for-and-barriers-to-antimicrobial-resistance-surveillance-by-lot-quality-assurance-sampling-in-livestock-findings-from-interviews-with-stakeholders-in-germany https://frankvanleth.com/publications/50902-the-clinical-usefulness-of-guideline-based-strategies-with-and-without-the-role-of-nonspecific-symptoms-to-predict-urinary-tract-infections-in-nursing-homes-a-decision-curve-analysis https://frankvanleth.com/publications/46701-neighbourhood-factors-and-tuberculosis-incidence-in-cape-town-a-negative-binomial-regression-and-spatial-analysis https://frankvanleth.com/publications/46702-the-plasma-kynurenine-to-tryptophan-ratio-as-a-biomarker-of-tuberculosis-disease-in-people-living-with-hiv-on-antiretroviral-therapy-an-exploratory-nested-case-control-study https://frankvanleth.com/publications/46582-relative-cost-of-multidrug-resistant-tb-medicines-in-europe https://frankvanleth.com/publications/46577-clinical-implications-of-molecular-drug-resistance-testing-for-mycobacterium-tuberculosis-a-2023-tbnet-resist-tb-consensus-statement https://frankvanleth.com/publications/46703-reasons-for-using-traditional-and-complementary-care-by-people-living-with-hiv-on-antiretroviral-therapy-and-association-with-interrupted-care-a-mixed-methods-study-in-eswatini https://frankvanleth.com/publications/46578-strengthening-primary-care-for-diabetes-and-hypertension-in-eswatini-study-protocol-for-a-nationwide-cluster-randomized-controlled-trial https://frankvanleth.com/publications/46581-monocyte-to-lymphocyte-ratio-and-hemoglobin-level-to-predict-tuberculosis-after-antiretroviral-therapy-initiation https://frankvanleth.com/publications/46579-predictive-performance-of-interferon-gamma-release-assays-and-the-tuberculin-skin-test-for-incident-tuberculosis-an-individual-participant-data-meta-analysis https://frankvanleth.com/publications/47385-estimating-the-contribution-of-subclinical-tuberculosis-disease-to-transmission-an-individual-patient-data-analysis-from-prevalence-surveys https://frankvanleth.com/publications/46583-unbiased-antimicrobial-resistance-prevalence-estimates-through-population-based-surveillance https://frankvanleth.com/publications/46586-cost-and-availability-of-drugs-and-treatment-regimens-and-availability-of-drug-resistance-testing-for-tuberculosis-in-europe https://frankvanleth.com/publications/46585-availability-and-costs-of-medicines-for-the-treatment-of-tuberculosis-in-europe https://frankvanleth.com/publications/46589-rifapentine-access-in-europe-growing-concerns-over-key-tuberculosis-treatment-component https://frankvanleth.com/publications/46584-neighbourhood-risk-factors-of-recurrent-tuberculosis-in-cape-town-a-cohort-study-using-geocoded-notification-data https://frankvanleth.com/publications/46588-reasons-for-and-factors-associated-with-positive-hiv-retesting-a-cross-sectional-study-in-eswatini https://frankvanleth.com/publications/46590-does-distance-to-healthcare-facility-affect-care-seeking-for-tb-related-symptoms-in-tanzania https://frankvanleth.com/publications/46587-incidence-and-factors-associated-with-active-tuberculosis-among-people-living-with-hiv-after-long-term-antiretroviral-therapy-in-thailand-a-competing-risk-model https://frankvanleth.com/publications/46595-antimicrobial-resistance-among-uropathogens-in-the-asia-pacific-region-a-systematic-review https://frankvanleth.com/publications/46592-use-and-impact-of-molecular-methods-for-detecting-drug-resistant-tb https://frankvanleth.com/publications/46596-defining-outcomes-of-tuberculosis-treatment-from-the-past-to-the-future https://frankvanleth.com/publications/46594-prediction-of-anti-tuberculosis-treatment-duration-based-on-a-22-gene-transcriptomic-model https://frankvanleth.com/publications/46593-monocyte-to-lymphocyte-ratio-as-a-predictor-of-tb-among-people-living-with-hiv https://frankvanleth.com/publications/46591-clinical-reasoning-underlying-guideline-nonadherence-in-urinary-tract-infections-in-nursing-homes https://frankvanleth.com/publications/46603-laboratory-based-versus-population-based-surveillance-of-antimicrobial-resistance-to-inform-empirical-treatment-for-suspected-urinary-tract-infection-in-indonesia https://frankvanleth.com/publications/46602-appropriateness-of-diagnosis-and-antibiotic-use-in-sepsis-patients-admitted-to-a-tertiary-hospital-in-indonesia https://frankvanleth.com/publications/46711-a-22-gene-transcriptomic-model-indicating-individual-therapy-durations-in-multidrug-resistant-tuberculosis https://frankvanleth.com/publications/46600-the-use-of-ultrasensitive-quantitative-pcr-to-assess-the-impact-of-primaquine-on-asymptomatic-relapse-of-plasmodium-vivax-infections-a-randomized-controlled-trial-in-lao-pdr https://frankvanleth.com/publications/46601-mass-drug-administrations-with-dihydroartemisinin-piperaquine-and-single-low-dose-primaquine-to-eliminate-plasmodium-falciparum-have-only-a-transient-impact-on-plasmodium-vivax-findings-from-randomised-controlled-trials https://frankvanleth.com/publications/46714-discovery-and-validation-of-a-personalized-risk-predictor-for-incident-tuberculosis-in-low-transmission-settings-authors https://frankvanleth.com/publications/46713-a-false-sense-of-confidence-the-perceived-role-of-inflammatory-point-of-care-testing-in-managing-urinary-tract-infections-in-dutch-nursing-homes-a-qualitative-study https://frankvanleth.com/publications/46597-diapers-as-promising-alternative-collection-method-for-urine-specimens-in-nursing-home-residents-a-noninferiority-study https://frankvanleth.com/publications/46712-sensitivity-of-c-reactive-protein-and-procalcitonin-measured-by-point-of-care-tests-to-diagnose-urinary-tract-infections-in-nursing-home-residents-a-cross-sectional-study https://frankvanleth.com/publications/46610-management-of-patients-with-multidrug-resistant-tuberculosis https://frankvanleth.com/publications/46608-rethinking-antimicrobial-resistance-surveillance-a-role-for-lot-quality-assurance-sampling https://frankvanleth.com/publications/46605-the-tuberculosis-network-european-trials-group-tbnet-ers-clinical-research-collaboration-addressing-drug-resistant-tuberculosis-through-european-cooperation https://frankvanleth.com/publications/46604-changes-in-disclosure-adherence-and-healthcare-interactions-after-the-introduction-of-immediate-art-initiation-an-analysis-of-patient-experiences-in-swaziland https://frankvanleth.com/publications/46609-sensitivity-of-point-of-care-testing-c-reactive-protein-and-procalcitonin-to-diagnose-urinary-tract-infections-in-dutch-nursing-homes-progress-study-protocol https://frankvanleth.com/publications/46614-time-to-revise-who-recommended-definitions-of-mdr-tb-treatment-outcomes https://frankvanleth.com/publications/46617-predictive-value-of-the-urinary-dipstick-test-in-the-management-of-patients-with-urinary-tract-infection-associated-symptoms-in-primary-care-in-indonesia-a-cross-sectional-study https://frankvanleth.com/publications/46615-testing-for-ltbi-more-of-the-same-or-a-step-forward https://frankvanleth.com/publications/46613-clinical-management-of-multidrug-resistant-tuberculosis-in-16-european-countries https://frankvanleth.com/publications/46611-pharmacy-based-hypertension-care-employing-mhealth-in-lagos-nigeria-a-mixed-methods-feasibility-study https://frankvanleth.com/publications/46612-relapse-free-cure-from-multidrug-resistant-tuberculosis-in-germany https://frankvanleth.com/publications/46616-treatment-responses-in-multidrug-resistant-tuberculosis-in-germany https://frankvanleth.com/publications/46622-antimicrobial-resistance-in-uropathogens-and-appropriateness-of-empirical-treatment-a-population-based-surveillance-study-in-indonesia https://frankvanleth.com/publications/46623-treatment-outcomes-of-mdr-tb-and-hiv-co-infection-in-europe https://frankvanleth.com/publications/46620-rapid-assessment-of-antimicrobial-resistance-prevalence-using-a-lot-quality-assurance-sampling-approach https://frankvanleth.com/publications/46618-reply-benefit-of-the-shorter-multidrug-resistant-tuberculosis-treatment-regimen-in-california-and-modified-eligibility-criteria https://frankvanleth.com/publications/46625-an-easy-tool-to-assess-ventilation-in-health-facilities-as-part-of-air-borne-transmission-prevention-a-cross-sectional-survey-from-uganda https://frankvanleth.com/publications/46624-tuberculosis-treatment-outcomes-in-europe-based-on-treatment-completion-not-cure https://frankvanleth.com/publications/46619-effect-of-secondary-preventive-therapy-on-recurrence-of-tuberculosis-in-hiv-infected-individuals-a-systematic-review https://frankvanleth.com/publications/46621-tuberculosis-resistance-conferring-mutations-with-fitness-cost-among-hiv-positive-individuals-in-uganda https://frankvanleth.com/publications/46633-more-on-treatment-outcomes-in-multidrug-resistant-tuberculosis https://frankvanleth.com/publications/46631-viral-load-and-risk-of-tuberculosis-in-hiv-infection https://frankvanleth.com/publications/46627-limited-benefit-of-the-new-shorter-multidrug-resistant-tuberculosis-regimen-in-europe https://frankvanleth.com/publications/46628-treatment-outcomes-in-multidrug-resistant-tuberculosis https://frankvanleth.com/publications/46629-intention-of-physicians-to-implement-guidelines-for-screening-and-treatment-of-latent-tuberculosis-infection-in-hiv-infected-patients-in-the-netherlands-a-mixed-method-design https://frankvanleth.com/publications/46630-population-impact-of-factors-associated-with-prevalent-pulmonary-tuberculosis-in-tanzania https://frankvanleth.com/publications/46632-prevalence-of-pulmonary-tuberculosis-in-adult-population-of-tanzania-a-national-survey-2012 https://frankvanleth.com/publications/46626-prevention-of-early-mortality-by-presumptive-tuberculosis-therapy-study-an-open-label-randomized-controlled-trial https://frankvanleth.com/publications/46637-tb-hiv-co-infection-in-the-netherlands-estimating-prevalence-and-under-reporting-in-national-registration-databases-using-a-capture-recapture-analysis https://frankvanleth.com/publications/46634-latent-tuberculosis-infection-as-a-target-for-tuberculosis-control https://frankvanleth.com/publications/46638-beyond-multidrug-resistant-tuberculosis-in-europe-a-tbnet-study https://frankvanleth.com/publications/46639-multidrug-resistant-tuberculosis-in-europe-2010-2011 https://frankvanleth.com/publications/46636-health-care-seeking-behaviour-among-people-with-cough-in-tanzania-findings-from-a-tuberculosis-prevalence-survey https://frankvanleth.com/publications/46717-implementation-of-tuberculosis-infection-prevention-and-control-in-mozambican-health-care-facilities https://frankvanleth.com/publications/46718-numbers-needed-to-treat-to-prevent-tuberculosis https://frankvanleth.com/publications/46635-factors-associated-with-poor-knowledge-among-adults-on-tuberculosis-in-bangladesh-results-from-a-nationwide-survey https://frankvanleth.com/publications/46720-validation-of-indirect-tuberculosis-treatment-adherence-measures-in-a-resource-constrained-setting https://frankvanleth.com/publications/46640-management-of-patients-with-multidrug-resistant-extensively-drug-resistant-tuberculosis-in-europe-a-tbnet-consensus-statement https://frankvanleth.com/publications/46719-design-of-pragmatic-trials-of-tuberculosis-interventions https://frankvanleth.com/publications/46646-embracing-the-challenges-of-hiv-tb-co-infection-in-children https://frankvanleth.com/publications/46641-antiretroviral-therapy-and-tuberculosis-does-the-regimen-matter https://frankvanleth.com/publications/46644-availability-price-and-affordability-of-anti-tuberculosis-drugs-in-europe-a-tbnet-survey https://frankvanleth.com/publications/46643-healthcare-workers-challenges-in-the-implementation-of-tuberculosis-infection-prevention-and-control-measures-in-mozambique https://frankvanleth.com/publications/46647-risk-assessment-of-tuberculosis-in-immunocompromised-patients-a-tbnet-study https://frankvanleth.com/publications/46645-care-seeking-in-tuberculosis-results-from-a-countrywide-cluster-randomised-survey-in-bangladesh https://frankvanleth.com/publications/46642-antimicrobial-drug-resistance-among-clinically-relevant-bacterial-isolates-in-sub-saharan-africa-a-systematic-review https://frankvanleth.com/publications/46652-health-workers-performance-in-the-implementation-of-patient-centred-tuberculosis-treatment-pct-strategy-under-programmatic-conditions-in-tanzania-a-cross-sectional-study https://frankvanleth.com/publications/46648-predictive-value-of-the-tuberculin-skin-test-among-newly-arriving-immigrants https://frankvanleth.com/publications/46722-entry-screening-of-immigrants-in-the-netherlands-for-latent-tuberculosis-a-cost-effectiveness-analysis https://frankvanleth.com/publications/46723-editorial-technical-assistance-to-tuberculosis-control-programmes-as-a-platform-forinfectious-disease-research https://frankvanleth.com/publications/46653-tb-diagnostic-process-management-of-patients-in-a-referral-hospital-in-mozambique-in-comparison-with-the-2007-who-recommendations-for-the-diagnosis-of-smear-negative-pulmonary-tb-and-extrapulmonary-tb https://frankvanleth.com/publications/46651-are-routine-tuberculosis-programme-data-suitable-to-report-on-antiretroviral-therapy-use-of-hiv-infected-tuberculosis-patients https://frankvanleth.com/publications/46649-comparison-of-direct-versus-concentrated-smear-microscopy-in-detection-of-pulmonary-tuberculosis https://frankvanleth.com/publications/46654-epidemiology-of-tuberculosis-in-an-urban-slum-of-dhaka-city-bangladesh https://frankvanleth.com/publications/46721-tuberculin-survey-in-bangladesh-2007-2009-prevalence-of-tuberculous-infection-and-implications-for-tb-control https://frankvanleth.com/publications/46650-risk-of-tuberculosis-after-antiretroviral-treatment-initiation-a-comparison-between-efavirenz-and-nevirapine-using-inverse-probability-weighting https://frankvanleth.com/publications/46657-adherence-to-tuberculosis-therapy-among-patients-receiving-home-based-directly-observed-treatment-evidence-from-the-united-republic-of-tanzania https://frankvanleth.com/publications/46662-multidrug-resistance-among-new-tuberculosis-cases-detecting-local-variation-through-lot-quality-assurance-sampling https://frankvanleth.com/publications/46656-missed-opportunities-in-tuberculosis-control-in-the-netherlands-due-to-prioritization-of-contact-investigations https://frankvanleth.com/publications/46661-role-of-the-quantiferon-tb-gold-in-tube-assay-in-screening-new-immigrants-for-tuberculosis-infection https://frankvanleth.com/publications/46659-adherence-by-dutch-public-health-nurses-to-the-national-guidelines-for-tuberculosis-contact-investigation https://frankvanleth.com/publications/46658-the-effect-of-tuberculosis-and-antiretroviral-treatment-on-cd4-cell-count-response-in-hiv-positive-tuberculosis-patients-in-mozambique https://frankvanleth.com/publications/46705-comparison-of-macroscopic-and-microscopic-assessment-of-specimens-collected-for-the-diagnosis-of-tuberculosis https://frankvanleth.com/publications/46704-socio-economic-position-in-tb-prevalence-and-access-to-services-results-from-a-population-prevalence-survey-and-a-facility-based-survey-in-bangladesh https://frankvanleth.com/publications/46655-implementation-and-effect-of-intensified-case-finding-on-diagnosis-of-tuberculosis-in-a-large-urban-hiv-clinic-in-uganda-a-retrospective-cohort-study https://frankvanleth.com/publications/46660-unrecognised-tuberculosis-at-antiretroviral-therapy-initiation-is-associated-with-lower-cd4-t-cell-recovery https://frankvanleth.com/publications/46725-earlier-initiation-of-antiretroviral-therapy-increased-tuberculosis-case-finding-and-reduced-mortality-in-a-setting-of-improved-hiv-care-a-retrospective-cohort-study https://frankvanleth.com/publications/46728-risk-for-progression-to-tuberculosis-among-arriving-immigrants-with-a-positive-igra https://frankvanleth.com/publications/46733-coverage-and-yield-of-tuberculosis-contact-investigations-in-the-netherlands https://frankvanleth.com/publications/46664-contact-tracing-in-low-incidence-tuberculosis-settings https://frankvanleth.com/publications/46731-measuring-socio-economic-data-in-tuberculosis-prevalence-surveys https://frankvanleth.com/publications/46665-guidelines-for-conducting-tuberculin-skin-test-surveys-in-high-prevalence-countries-second-edition https://frankvanleth.com/publications/46696-guidelines-for-conducting-tuberculin-skin-test-surveys-in-high-prevalence-countries https://frankvanleth.com/publications/46732-prevalence-of-smear-positive-tuberculosis-in-persons-aged-15-years-in-bangladesh-results-from-a-national-survey-2007-2009 https://frankvanleth.com/publications/46667-evaluation-of-the-genotype-mtbdrplus-assay-as-a-tool-for-drug-resistance-surveys https://frankvanleth.com/publications/46726-highlights-of-a-symposium-malaria-where-are-we-today-where-are-we-going https://frankvanleth.com/publications/46730-comment-on-predictors-of-immune-recovery-and-the-association-with-late-mortality-while-on-antiretroviral-treatment-in-cambodia https://frankvanleth.com/publications/46663-health-seeking-norms-for-tuberculosis-symptoms-in-southern-angola-implications-for-behaviour-change-communications https://frankvanleth.com/publications/46666-incidence-and-predictors-of-mortality-and-the-effect-of-tuberculosis-immune-reconstitution-inflammatory-syndrome-in-a-cohort-of-tb-hiv-patients-commencing-antiretroviral-therapy https://frankvanleth.com/publications/46669-practice-guideline-prevention-diagnosis-and-treatment-of-tuberculosis-in-patients-with-an-hiv-infection https://frankvanleth.com/publications/46670-the-tuberculin-skin-test-a-comparison-of-ruler-and-calliper-readings https://frankvanleth.com/publications/46668-latent-tuberculosis-infection-and-interferon-gamma-release-assays-what-new-knowledge-did-we-gain-through-the-journal-in-2009 https://frankvanleth.com/publications/46734-national-anti-tuberculosis-drug-resistance-study-in-tanzania https://frankvanleth.com/publications/46672-projection-of-the-number-of-patients-with-tuberculosis-in-the-netherlands-in-2030 https://frankvanleth.com/publications/46671-annual-meeting-of-the-tuberculosis-surveillance-and-research-unit-2008 https://frankvanleth.com/publications/46736-inclusion-of-information-on-risk-factors-socio-economic-status-and-health-seeking-in-a-tuberculosis-prevalence-survey https://frankvanleth.com/publications/46673-patient-centred-tuberculosis-treatment-delivery-under-programmatic-conditions-in-tanzania-a-cohort-study https://frankvanleth.com/publications/46737-risk-factors-for-smear-negative-and-culture-positive-results-among-pulmonary-tuberculosis-patients-in-mwanza-tanzania https://frankvanleth.com/publications/46676-determination-of-clinically-relevant-cutoffs-for-hiv-1-phenotypic-resistance-estimates-through-a-combined-analysis-of-clinical-trial-and-cohort-data https://frankvanleth.com/publications/46739-measuring-tuberculosis-burden-trends-and-the-impact-of-control-programmes https://frankvanleth.com/publications/46674-estimation-of-the-incidence-of-tuberculosis-in-the-netherlands-in-2030 https://frankvanleth.com/publications/46738-organisation-of-a-tuberculosis-prevalence-survey https://frankvanleth.com/publications/46740-prevalence-of-tuberculous-infection-and-incidence-of-tuberculosis-a-re-assessment-of-the-styblo-rule https://frankvanleth.com/publications/46741-tuberculosis-prevalence-surveys-rationale-and-cost https://frankvanleth.com/publications/46675-assessment-of-patient-preference-in-allocation-and-observation-of-anti-tuberculosis-medication-in-three-districts-in-tanzania https://frankvanleth.com/publications/46677-implementation-of-a-national-anti-tuberculosis-drug-resistance-survey-in-tanzania https://frankvanleth.com/publications/46706-methodological-standards-in-non-inferiority-aids-trials-moving-from-adherence-to-compliance-response https://frankvanleth.com/publications/46679-plasma-lipid-concentrations-after-1-5-years-of-exposure-to-nevirapine-or-efavirenz-together-with-stavudine-and-lamivudine https://frankvanleth.com/publications/46681-the-use-of-the-non-nucleoside-reverse-transcriptase-inhibitors-nevirapine-and-efavirenz-in-the-treatment-of-patients-with-a-chronic-hiv-i-infection https://frankvanleth.com/publications/46678-long-term-experience-with-combination-antiretroviral-therapy-that-contains-nelfinavir-for-up-to-7-years-in-a-pediatric-cohort https://frankvanleth.com/publications/46680-epstein-barr-virus-infects-b-and-non-b-lymphocytes-in-hiv-1-infected-children-and-adolescents https://frankvanleth.com/publications/46686-pharmacokinetics-of-nevirapine-once-daily-versus-twice-daily-dosing-in-the-2nn-study https://frankvanleth.com/publications/46685-are-adverse-events-of-nevirapine-and-efavirenz-related-to-plasma-concentrations https://frankvanleth.com/publications/46684-nevirapine-and-efavirenz-pharmacokinetics-and-covariate-analysis-in-the-2nn-study https://frankvanleth.com/publications/46682-plasma-hiv-1-rna-decline-within-the-first-two-weeks-of-treatment-is-comparable-for-nevirapine-efavirenz-or-both-drugs-combined-and-is-not-predictive-of-long-term-virologic-efficacy-a-2nn-substudy https://frankvanleth.com/publications/46683-protease-inhibitors-and-non-nucleoside-reverse-transcriptase-inhibitors-have-a-comparable-effect-on-the-cd4-cell-change-after-switching-to-tenofovir-based-regimens https://frankvanleth.com/publications/46743-cytomegalovirus-rather-than-hiv-triggers-the-outgrowth-of-effector-cd8-cd45ra-cd27-t-cells-in-hiv-1-infected-children https://frankvanleth.com/publications/46744-lipid-profiles-in-hiv-1-infected-individuals-receiving-combination-antiretroviral-therapy-are-different-protease-inhibitors-or-non-nucleoside-reverse-transcriptase-inhibitors-associated-with-different-lipid-profiles https://frankvanleth.com/publications/46687-quality-of-life-in-patients-treated-with-first-line-antiretroviral-therapy-containing-nevirapine-and-or-efavirenz https://frankvanleth.com/publications/46690-differential-cd4-t-cell-response-in-hiv-1-infected-patients-using-protease-inhibitor-based-or-nevirapine-based-highly-active-antiretroviral-therapy https://frankvanleth.com/publications/46689-nevirapine-and-efavirenz-elicit-different-changes-in-lipid-profiles-in-antiretroviral-therapy-naive-patients-infected-with-hiv-1 https://frankvanleth.com/publications/46745-comparison-of-first-line-antiretroviral-therapy-with-regimens-including-nevirapine-efavirenz-or-both-drugs-plus-stavudine-and-lamivudine-a-randomised-open-label-trial-the-2nn-study https://frankvanleth.com/publications/46688-highly-active-antiretroviral-therapy-with-or-without-mycophenolate-mofetil-in-treatment-naive-hiv-1-patients https://frankvanleth.com/publications/46692-identifying-malnourished-children-may-not-be-easy https://frankvanleth.com/publications/46693-use-of-composite-end-points-to-measure-clinical-events https://frankvanleth.com/publications/46691-a-randomized-trial-to-study-first-line-combination-therapy-with-or-without-a-protease-inhibitor-in-hiv-1-infected-patients https://frankvanleth.com/publications/46694-highly-active-antiretroviral-therapy-induced-lipodystrophy-has-minor-effects-on-human-immunodeficiency-virus-induced-changes-in-lipolysis-but-normalizes-resting-energy-expenditure https://frankvanleth.com/publications/46695-nevirapine-containing-antiretroviral-therapy-in-hiv-1-infected-patients-results-in-an-anti-atherogenic-lipid-profile https://frankvanleth.com/publications/46750-malnutrition-more-than-the-eye-can-see https://frankvanleth.com/projects/5385-lot-quality-assurance-sampling https://frankvanleth.com/projects/5389-syndemics https://frankvanleth.com/projects/5387-treatment-as-antimicrobial-stewardship-project https://frankvanleth.com/projects/5388-healthy-entrepeneurs https://frankvanleth.com/people/4517-untitled https://frankvanleth.com/courses/3857-whopen https://frankvanleth.com/courses/3893-progress https://frankvanleth.com/courses/3895-evolve https://frankvanleth.com/courses/3892-spin https://frankvanleth.com/courses/3858-tuberculosis-prevalence-surveys https://frankvanleth.com/courses/3896-multidrug-resistant-tuberculosis-in-europe https://frankvanleth.com/courses/3897-community-based-dot https://frankvanleth.com/courses/3894-tb-screen https://frankvanleth.com/posts/4021-neighbourhood-characteristics-and-recurrent-tuberculosis https://frankvanleth.com/posts/4018-drug-resistant-tuberculosis-in-europe https://frankvanleth.com/posts/4016-distance-to-health-facilities-and-care-seeking https://frankvanleth.com/posts/4023-urinary-tract-infections-in-people-of-older-age https://frankvanleth.com/pages/7536-invited-talks https://frankvanleth.com/pages/7511-public_resources